Table 2.
Patient Characteristics (n = 4,073)
| Age (years)a | 61.0 (52.0 ‐ 69.0) |
| Sex (female/male) | 1,871/2,202 |
| Smoking (yes/no/unknown) | 1,059/2,726/288 |
| BMI (kg/m2)a | 25.0 (23.1 ‐ 27.4) |
| AST (IU/L)a | 24 (19 ‐ 33) |
| ALT (IU/L)a | 26 (18 ‐ 49) |
| Gamma‐glutamyl transpeptidase (IU/L) | 32 (22 ‐ 55) |
| Albumin (g/dL)a | 4.4 (4.2 ‐ 4.6) |
| Total bilirubin (mg/dL)a | 0.6 (0.5 ‐ 0.8) |
| Total cholesterol (mg/dL)a | 204 (179 ‐ 228) |
| Triglycerides (mg/dL)a | 133 (94 ‐ 191) |
| Low‐density lipoprotein cholesterol (mg/dL)a | 124 (103 ‐ 146) |
| High‐density lipoprotein cholesterol (mg/dL)a | 47 (40 ‐ 56) |
| Platelet count (×104/mm3)a | 24.5 (20.6 ‐ 29.4) |
| Fasting plasma glucose (mg/dL)a | 92.0 (85.0 ‐ 100.0) |
| Hemoglobin A1c (%)a | 5.6 (5.2 ‐ 7.0) |
| Systolic blood pressure (mmHg)a | 146 (132 ‐ 163) |
| Diastolic blood pressure (mmHg)a | 77 (68 ‐ 87) |
| Diabetes mellitus (yes/no) | 1,254/2,819 |
| Follow‐up duration (years)a | 7.1 (4.8 ‐ 9.2) |
| US fatty liver scores (1/2/3/4/5/6) | 231/1,034/1,033/1,029/531/215 |
| NFSa | −1.83 (−2.85 to −0.81) |
| FIB‐4 indexa | 1.16 (0.81 ‐ 1.62) |
| Deaths | 179 |
| Causes | |
| Liver‐related diseases | 9/179 (5.0%) |
| Primary liver cancer | 5 |
| Liver failure | 4 |
| Non‐liver‐related diseases | 170/179 (95.0%) |
| Malignancies | 83/170 (48.8%) |
| Digestive malignancies | 36 |
| Respiratory malignancies | 19 |
| Hematological malignancies | 13 |
| Other | 15 |
| Nonmalignant diseases | 87/170 (51.2%) |
| Digestive diseases | 4 |
| Respiratory diseases | 27 |
| Cardiovascular disease | 33 |
| Cerebrovascular diseases | 9 |
| Injury | 3 |
| Other | 11 |
a
Values are expressed as medians (interquartile range).
Abbreviation: BMI, body mass index.